Search

Search Constraints

You searched for: Author/Creator D'Adamo, David

Search Results

1. A phase 1 study of eribulin mesylate (E7389), a novel microtubule‐targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314). Issue 8 (2nd May 2018)

2. Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial. Issue 10028 (16th April 2016)

4. Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours. (October 2019)

5. Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study. (April 2023)